The in vivo and in vitro experiments demonstrated that ZIP14 expression was up-regulated by turpentine-induced inflammation and lipopolysaccharide administration through IL-6, and that this zinc transporter most likely plays a major role in the mechanism responsible for hepatic zinc accumulation and hypozincemia that accompanied the acute-phase response to inflammation and infection. The gene discussed is SLC39A14; the disease is infection.